Quantification of serum hepatitis B surface antigen in predicting the response of pegylated interferon alfa-2a in HBeAg-positive chronic hepatitis B with prior lamivudine exposure

被引：0
|
作者：
Min Weng
Wei-Zheng Zeng
Xiao-Ling Wu
Yong Zhang
Ming-De Jiang
Zhao Wang
De-Jiang Zhou
Xuan He
机构：
[1] General Hospital of Chengdu Military Region of PLA,Department of Digestion
来源：
Virology Journal | / 10卷
关键词：
Chronic hepatitis B; Lamivudine exposure; Pegylated interferon α-2a; Hepatitis B surface antigen quantification; Predictability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
    Chang, TT
    Gish, RG
    de Man, R
    Gadano, A
    Sollano, J
    Chao, YC
    Lok, AS
    Han, KH
    Goodman, Z
    Zhu, J
    Cross, A
    DeHertogh, D
    Wilber, R
    Colonno, R
    Apelian, D
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1001 - 1010
  • [22] VIROLOGICAL RESPONSE TO TREATMENT WITH PEGYLATED INTERFERON ALFA-2A OF CHRONIC HEPATITIS B IN CHILDREN
    Pawlowska, Malgorzata
    Halota, Waldemar
    HEPATOLOGY, 2009, 50 (04) : 633A - 634A
  • [23] SERUM HEPATITIS B SURFACE ANTIGEN LEVEL IS ASSOCIATED WITH LIVER FIBROSIS IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B
    Cheng, P. -N.
    Tsai, H. -W.
    Chang, T. -T.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S145 - S146
  • [24] SERUM LEVELS OF ANTI-HBC ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS
    Brakenhoff, Sylvia
    Oliviera, Jeffrey
    De Knegt, Robert J.
    Van der Eijk, Annemiek A.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    De Man, Robert A.
    Boonstra, Andre
    Sonneveld, Milan J.
    HEPATOLOGY, 2021, 74 : 441A - 442A
  • [25] Pegylated interferon alfa-2a (40KD) is efficacious and safe in treatment of HBeAg-positive children with chronic hepatitis B: Peg-B-Active study
    Wirth, Stefan
    Zhang, Hongfei
    Hardikar, Winita
    Schwarz, Kathleen B.
    Sokal, Etienne M.
    Yang, Weibo
    Fan, Huimin
    Morozov, Vyacheslav G.
    Mao, Qing
    Nasmyth-Miller, Clare
    Huang, Yang
    Yang, Lei
    Wat, Cynthia
    HEPATOLOGY, 2016, 64 : 44A - 45A
  • [26] Pegylated interferon-α2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B
    ter Borg, MRNJ
    Janssen, HLA
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (05) : 391 - 391
  • [27] Characterization of Hepatitis B Surface Proteins in HBeAg-positive Patients with Chronic Hepatitis B (CHB) Treated With PegInterferon Alfa-2a (40KD)
    Rinker, Franziska
    Bremer, Corinna M.
    Wiegand, Steffen B.
    Bremer, Birgit
    Manns, Michael P.
    Wedemeyer, Heiner
    Yang, Lei
    Pavlovic, Vedran
    Wat, Cynthia
    Glebe, Dieter
    Kraft, Anke R.
    Cornberg, Markus
    HEPATOLOGY, 2015, 62 : 1196A - 1197A
  • [28] Efficacy and safety of pegylated interferon-α2a in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B
    Suh, Dong Jin
    Lee, Han Chu
    Byun, Kwan Soo
    Cho, Mong
    Kweon, Young Oh
    Tak, Won Young
    Chon, Chae Yoon
    Koh, Kwang Cheol
    Lee, Young Sok
    ANTIVIRAL THERAPY, 2013, 18 (06) : 765 - 773
  • [29] Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis
    Zhang, Zhan-qing
    Wang, Yan-bing
    Lu, Wei
    Liu, Dan-ping
    Shi, Bi-sheng
    Zhang, Xiao-nan
    Huang, Dan
    Li, Xiu-fen
    Zhou, Xin-lan
    Ding, Rong-rong
    ANNALS OF LABORATORY MEDICINE, 2019, 39 (01) : 67 - 75
  • [30] Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients
    Chen, Gong-Ying
    Zhu, Meng-Fei
    Zheng, Da-Liang
    Bao, Yan-Ting
    Wang, Jie
    Zhou, Xiang
    Lou, Guo-Qiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (25) : 8195 - 8200
12345